Macquarie Group LTD Epizyme, Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$0.42 - $1.48 $1,105 - $3,893	-2,631 Reduced 1.28%	203,200 $299,000
Q1 2021 May 14, 2021	SELL	$7.45 - $12.32 $7,815 - $12,923	-1,049 Reduced 0.51%	205,831 $1.79 Million
Q2 2020 Aug 11, 2020	SELL	$13.68 - $20.46 $9,726 - $14,547	-711 Reduced 0.34%	206,880 $3.32 Million
Q1 2020 May 15, 2020	BUY	$14.83 - $26.72 $65,118 - $117,327	4,391 Added 2.16%	207,591 $3.22 Million
Q3 2018 Nov 15, 2018	SELL	$9.5 - $13.75 $386,279 - $559,088	-40,661 Reduced 16.67%	203,200 $2.15 Million
Q2 2018 Aug 14, 2018	BUY	$12.85 - $18.45 $22,359 - $32,103	1,740 Added 0.72%	243,861 $3.3 Million
Q1 2018 May 11, 2018	BUY	$12.5 - $19.75 $2 Million - $3.15 Million	159,636 Added 193.53%	242,121 $4.3 Million
Q4 2017 Feb 15, 2018	BUY	$11.55 - $20.1 $477,996 - $831,838	41,385 Added 100.69%	82,485 $1.04 Million
Q3 2017 Nov 08, 2017	BUY	$12.7 - $19.25 $521,969 - $791,175	41,100	41,100 $783,000

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.